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ABSTRACT 
Objective: We studied the effect of stromal derived factor-1 (SDF-1) and celecoxib for increasing the amount of neural stem cells in the lesion zone 
and clinical outcomes of spontaneous intracerebral hemorrhage. 
Methods: Twenty-eight rats, strain Wistar, divided into four groups: control, treated with celecoxib, SDF-1, and the combination of celecoxib+SDF-1. 
The neural stem cells identified by immunohistochemistry procedures with Nestin as primary antibodies and the levels of proliferation were 
assessed by Ki-67 as primary antibodies. The clinical outcomes were examined by Bederson scale.  
Results: This study revealed the combination treatment group had the highest histoscores of Nestin and highest of Ki-67 histoscores for SDF-1 
group. The amount of neural stem cells in the lesion zone of treatments groups was higher than controls (p<0.005), but similar between treated 
groups (P>0.05). The proliferation levels were higher in SDF-1 group (P<0.05), and the clinical outcomes back to normal were highest in 
combination therapeutic groups, even though not different when compared to another group (p>0.05).  
Conclusion: The results suggest celecoxib, SDF-1, and the combination of celecoxib+SDF-1 can increase neural stem cells in spontaneous 
intracerebral hemorrhage, and SDF-1 increased proliferation levels. The clinical outcomes were not significantly different between rats, regardless 
of the fact that almost all of rats in the combination group were back to normal. 
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INTRODUCTION 
Spontaneous intracerebral hemorrhage is one of disease when 
intracranial blood vessels ruptured, and the neurologic deficits will 
appear due to the neuron cells dead. Some risk factors of 
spontaneous intracerebral hemorrhage (SICH) are hypertension, 
diabetes mellitus and also hypercholesterolemia [1, 2]. The 
incidence of SICH in Asia almost 25%, and mortality rate between 
34.6% until 42% all over the world [3-9]. One of dead cell 
mechanisms in SICH is neuroinflammation because of blood product 
degradation, leucocytes infiltration, and activated microglia. 
Cyclooksigenase-2 (cox2) is one of many toxic factors which expressed 
by activated microglia, and another were reactive oxygen species 
(ROS), matrix metalloproteinase (MMP), prostaglandin (PG), tumor 
necrotizing factor-α (TNFα), and interleukin 1β (IL-β) [10-15].  
When expression of cox2 increased, fas ligand (FasL) will be 
increased and cell death by apoptosis will start [16]. Neuron cells 
can also die from NMDA receptor-mediated glutamate toxicity, and 
inhibition of cox2 can protect the cells from those mechanisms [17]. 
Chu K et al. investigated of celecoxib as selective cox2 inhibitor in 
SICH models. They concluded that inflammation decreased, and 
clinical outcome of SICH models was better than controls [18]. 
Besides neuroinflammation process, there is neuro endogenesis in 
SICH which signed by migrated of neural stem cells from their niches 
in the hippocampus and subventricular zones. The migrations were 
influenced by stromal derived factor-1 (SDF-1). Unfortunately, most 
of the neural stem cells died and failed to change the death mature 
cells by SICH [19-22]. 
This study analyzed the effect of substitutes of SDF-1 as the 
migration factor for increasing the quantity of NSC migrates to the 
lesion zones and in combination with celecoxib as selective cox2 
inhibitor decreased neuroinflammation to decrease cell death. While 
NSC increased in the lesion zone and neuroinflammation decreased, 
the quantity of survived NSC in the lesion zone will increase, and 
hopefully the outcome of SICH will be better.  
MATERIALS AND METHODS 
Twenty-eight male Wistar rats weight 200-300 grams were taken 
for the study. The rats were maintained in normal temperature 
room 28-31 °C, and free access to water and foods. The study was 
performed after approved by Health Research Ethical Committee of 
Padjadjaran University, West Java, Indonesia, with approval number 
130/UN6. C2.1.2/KEPK/PN/2013-11st
Intracerebral hemorrhage models 
April 2013.  
The rats were anesthetized with ketamine injected intramuscular 
using dose 1 mg/kg body weight. The skin of the head was washed 
by antiseptic and incised. The striatum was reached by a 26-G 
needle inserted 6.0 mm deep through a small burr hole made 3.5 
mm right of and at the anteroposterior level of bregma. Then 
autologous blood (0.1 ml) was taken from the tail and infused to the 
striatum over 10 min, and the needle was removed slowly. The burr 
hole was sealed by bone wax, and the wound sutured [23, 24].  
Treatment procedures  
28 rats were divided randomly into 4 groups. The first group rats were 
not treated and assigned as a control. The second group rats were 
treated by injecting with celecoxib intraperitoneally with dose 20 
mg/kg body weight, once a day for five days [12]. Meanwhile, the 
wounds of the third and fourth groups were reopened and inserted 
the 26-G needle to the lesion zone, then injected 0.1 ml SDF-1 with 
dose 500 ng/ml [25]. The needle was removed and the wound 
sutured. Beside SDF-1 treatment, the rats of the fourth group was 
injected with celecoxib intraperitoneally as same as the second group.  
Temperatures and body weights 
The temperatures and body weights of rats were measured before 
the procedures of intracerebral hemorrhage modeling, and the 14th 
day before the rats were euthanized with injected of 100 mg 
pentotal intraperitoneally.  
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Bederson scale and brain fixation 
The clinical performances of rats were examined by Bederson scale 
at three hours after auto blood infusion of the striatum, and the 
14th
The immunohistochemistry was started with a block of paraffin, cut 
about 4-5 micron and coated, then incubated 38-40 °C one night. The 
tissues were deparaffinized by xylol and alcohol 90%, 80%, and 
70%. Then the tissues were washed by water and hot sodium citrate 
buffer, entered to the decloaking chamber for 30 min. After cooled 
30 min in temperature room and washed by Phospat Buffer Saline 
(PBS) for 5 min, tissues were peroxidase by H
day before the rats euthanized. Bederson scale is divided into 
three categories: normal (no neurologic deficit), moderate (forelimb 
flexion), and severe when the forelimb was flexion with decreased 
resistance to lateral push, or circle to paretic side [26]. After 
euthanized, the brains were removed from the skulls and fixed by 
formalin and paraffin block. The histopathology process was done 
by immunohistochemistry using an antibody of Nestin and also Ki-
67 under the light microscope at 400 x magnifications. The nestin 
marker was used to identify and counted of neural stem cells in the 
lesion zone, and Ki-67 for proliferation levels [19, 27, 28]. 
Immunohistochemistry 
2O2
Semi-quantitative evaluation of Nestin and Ki-67 staining 
. The tissues were 
rinsing with PBS and dropped by blocking serum before incubated 
for 10 min. The tissues were washed by PBS and gave primary 
antibody nestin. Incubated for 60 min, then rinsing by PBS. After 
rinsing with PBS, slides were incubated for 10 min at room 
temperature with biotin-conjugated secondary antibodies, attended 
by incubated with streptavidin-conjugated peroxidase working 
solution for 10 min. Subsequently, sections were stained for 10 min 
with 3, 3′ -diaminobenzidine tetra hydrochloride (DAB), counter-
stained with haematoxylin, dehydrated, and mounted. Those 
procedures were further performed to another specimen using ki-67 
as primary antibody [19, 28]. 
The expression of nestin was examined as the intensity of staining 
by gave numerical with 0= negative, 1=light, 2= moderate, 3= 
intense. The different intensity percentages of positive cells were 
demonstrated as the ratio of positive cells. The final histoscore was 
0-3, calculated from the sum of (0 x negative%, 1 x %weakly, 2 x % 
moderately, 3 x % intense). The cells proliferation were calculated 
by Ki-67 staining, which counted of the proportion of positive cell 
(chocolate nucleus) with whole cells, and results were: 0 (negative), 
1 (<5% positive), 2 (5%-10% positive) and 3 (>10% positive). 
Statistical analysis 
Kolmogorov-smirnov test and analysis of variance (ANOVA) were 
used for the data of temperatures and body weights. 
Immunohistochemistry data and clinical outcomes were analyzed by 
ANOVA and Cross Tab (Chi-square test). 
RESULTS 
In this study, two of 28 eights spontaneous intracerebral rats were 
dead. One rat from controls was dead on the day after treatment 
because of bleeding in the cortical area, and the other one from the 
combination group was dead on the sixth day due to infection. The 
temperatures and body weights of rats showed in table 1. Based on 
homogeneity and Anova test, the temperatures and body weights of 
rats were similar, before and after treatment, p value>0.05, means 
the rates could be compared with each other as samples. 
 
Table 1: Temperatures and body weights of rats before and after treatment 
  Treatment groups  
Control Celecoxib SDF-1 Celecoxib +SDF-1  p  
1. Body weight day 1 (g):      
-Mean (SD) 218.0(5.5) 212.9(11.1) 208.7(8.6) 220.4(10.1) 0.098** 
-Range 210-225 200-226 200-220 200-230  
2. Body weight day 14 (g):      
-Mean (SD) 228.5(14.5)* 226.0(14.7)* 213.4(12.0) * 230.8(14.1)* 0.129** 
-Range 203-243 204-241 196-232 204-245  
3. Temperature day 1 ( °C):      
-Mean (SD) 36.9 (0.4) 36.9 (0.4) 37.1 (0.3) 36.7 (0.2) 0.210** 
-Range 36.4-37.5 36.4-37.6 36.6-37.4 36.4-36.9  
4. Temperature day 14 ( °C):      
-Mean (SD) 37.1(0,3)*  36.9 (0.2) * 37.0 (0.3) * 36.9 (0.2)* 0.627** 
-Range 36.6-37.5 36.5-37.2 36.6-37.4 36.6-37.2  
 * No significant different between the first day and fourteenth days, p>0.05, **No significant different between controls and treated rats, based on 
analysis of variance (ANOVA), p>0.05  
 
The immunohistochemistry pictures were seen in fig. 1, arrows 
showed neural stem cells with nestin expression (a) and ki-67 
expression (b).  
 
 
Fig. 1: Photomicrograph of immunohistochemistry, under light 
microscopes magnification 400x. a. Cell with immunoexpression of 
Nestin b. Cell with immunoexpression of Ki-67 
The results of histoscores were seen in table 2. Histoscore of Ki-67 
from all controls was negative, while only two from seven of 
celecoxib-treated rats were positive for proliferation<5%. All seven 
SDF-1 treated rats were positive, and most of them with 
proliferation<5%. Four of six combinations treated rats were 
positive with proliferation<5%, and two of them were negative.  
The histoscore of nestin from all controls showed weakly 
positive, while most of the celecoxib-treated rats were 
moderately positive. On SDF-1 and combination treated rats, the 
nestin histoscore showed a balance between moderately positive 
and strongly positive. 
The comparison of histoscore results between all groups was 
seen in table 3. The Ki-67 histoscore between controls and 
celecoxib groups were not different significantly, but higher on 
SDF-1 and combination groups. When comparing between SDF-1 
and celecoxib groups, the Ki-67 histoscore was higher 
significantly different in SDF-1 group. Histoscore of nestin from 
all treatment groups was significantly higher than controls, but 
not different significantly between one treated to another 
treated groups. 
Sinurat et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 7, 399-403 
 
401 
Table 2: Immunohistochemistry results (Histoscore of Ki-67 and Nestin) 
 Treatment groups  
Control(n=6) Celecoxib(n=7) SDF-1(n=7) Celecoxib+SDF-1 (n=6) 
1. Histoscore Ki-67     
0 6 5 0 2 
1 0 2 5 4 
2 0 0 2 0 
3 0 0 0 0 
 Mean(SD) 0(0) 0.28(0.5) 0.28(0.5) 0.67(0.5) 
 Median 0 0 1 1 
 Range 0 0-1 0-1 0-1 
2. Histoscore Nestin     
0 0 0 0 0 
1 6 1 1 1 
2 0 4 3 2 
3 0 2 3 3 
 Mean(SD) 1(0) 2.14(0.7) 2.28(0.7) 2.33(0.8) 
 Median 1 2 2 2.50 
 Range 1-1 1-3 1-3 1-3 
Results of histoscore ki-67: 0 (negative), 1(<5% positive), 2(5%-10% positive);3(>10% positive); histoscore of nestin: 0(negative); 1(weakly); 
2(moderately); 3(intense); n = amount of rats 
 
Table 3: Comparisons of Ki-67 and Nestin histoscore 
 Group vs group Histoscore Ki-67 Histoscore nestin 
 Z  p M-W Z  p  M-W 
1. Control vs Celecoxib 1.268 0.171 2.847 0.004* 
2. Control vs SDF-1 3.261 0.001** 2.832 0.005* 
3. Control vs combination  2.345 0.019** 2.708 0.007* 
4. Celecoxib vs SDF-1 2.734 0.006*** 0.421 0.674 
5. Celecoxib vs combination 1.320 0.187 0.544 0.587 
6. SDF-1 vs combination  1.927 0.054 0.155 0.877 
 Combination: Celecoxib+SDF-1; ZM-W
 
 = Mann-Whitney test, p<0.05, *Treated groups highly significant compared to control group, p<0.05, **SDF-1 
and combination highly significant compared to control group, p<0.05, ***SDF-1 highly significant compared to celecoxib group, p<0.05 
In table 4, the clinical outcome was reviewed and compared. After 
all, rats were infused by their auto blood to their striatum, all of 
them suffered a severe neurologic deficit. On 14th
  
 days, after 
treatments, half of control groups had a moderate neurologic deficit, 
while most of the treatment groups were normal and especially in 
combination group only one rat had a moderate deficit. Even though 
clinical outcomes of treated rats group showed better than controls, 
but the chi-square test results did not show differently. 
Table 4: Clinical outcome of SICH models by Bederson scale 
Bederson scale  Treatment groups  
Control(n=7) Celecoxib(n=7) SDF-1(n=7) Celecoxib+SDF-1 (n=7)  p 

















































 * One rat was dead, each group., ** Based on chi-square test, p<0.05, clinical outcome non-significant between treated groups and controls  
 
DISCUSSION  
The authors studied the role of celecoxib, SDF-1, and a combination 
of them for increasing the neural stem cells population in the lesion 
zone and their clinical impact for the outcome of spontaneous 
intracerebral hemorrhage in animal models. Twenty-eight rats 
successfully became SICH rats after auto blood transfusion into their 
striatum, showed severe neurologic deficit due to Bederson scale, 
but two rats were dropping out of the study because died before 
euthanasia due to infection and bleeding.  
Histoscore of Ki-67 from controls and celecoxib groups were almost 
all negative. Suggest the proliferation level was low, and celecoxib 
did not impact the proliferation level. Some factors impacts 
proliferation levels in SICH already known were a basic fibroblast 
growth factor, epidermal growth factor, insulin like growth factor-1 
and brain-derived neurotrophic factor (BDNF) started on 72 h after 
hemorrhage and peak on 7th 
In the SDF-1 group revealed that histoscore Ki-67 were higher than 
the other groups, means SDF-1 impacts to increase the proliferation 
days, then decreased until 28 d [19, 29, 30]. 
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level of cells in SICH. That issue is new, and supports Huang C et al., 
and Arimitsu N et al. that stated interaction of SDF-1 and chemokine 
receptor type 4 (CXCR4) will activate mitogen-activated protein 
kinase (p38MAPK), ribosomal S6 kinase (RS6K), c-jun and Paxillin of 
stem cells, then activated proliferative and chemotaxis of stem cells 
[31, 32]. MAPK involved in the cell migration process by organized 
of actin, while RS6K was activated by extracellular signal-regular 
kinases (ERK) and important for provoked phosphorylation process 
of cytoskeleton molecules, needed for migration and elongation of 
neurites. SDF-1 is playing the role of cell migration via CXCR4–SDF 
axis, and by different expression of SDF-1 in the niche and lesion 
zone. In this study, the quantity of SDF-1 in the lesion zone had to be 
added by substituting from outside, then the different level between 
lesion zone and niche becomes more and NSC increased in SDF-1 
and combination group. This result supports Kokovay E et al. [25], 
Mori et al. [33], Kucia M et al. [34], and Imitola J et al. [35], studied 
SDF-1 involve for migrated and motility of cells. 
Histoscore of nestin revealed lowest in the control group, higher for 
celecoxib group, and highest of SDF-1 and combination groups. It 
means neural stem cells in the lesion zone were significantly 
increased by all treatment, especially for SDF-1 and combination 
groups. When there is no injury or inflammation, the neural stem 
cells were stated in the niche, subventricular zone and hippocampus 
[36]. NSC expressed intermediate filament protein (nestin), and the 
NSC can stay for a long time, do not involve in the cell cycle, and then 
died due to apoptosis [37-39]. When there is an injury of SICH, 
neural stem cells from niche migrated to lesion zone as the impact of 
thrombin, vascular endothelial growth factor (VEGF), and SDF-1 [32, 
40]. Thrombin-mediated neurogenesis process via protease 
activated receptor-1 (PAR-1), and par-1 modulate angiopoietin for 
angiogenesis [40]. Celecoxib decreased the inflammatory process by 
inhibited producers of Prostaglandin E2 (PGE2) and decreased fas 
ligand expression which important for activated apoptosis via 
caspase 8 and 3 [16, 41-43]. Cox2 inhibitor also inhibited N-methyl-
D-aspartate (NMDA) receptor activation which increased ca+intra 
cell and mitochondrial failure, and cell dead [17, 44-46]. 
Although NSC increased by the combination of SDF-1 and celecoxib, 
there were not significantly different between the combination 
group versus each treatment, SDF-1 or celecoxib groups. This result 
may be because of limited neural stem cells in the niche in one 
periodic time. It was also stated by Takahashi et al. [47], and 
Sommer L et al. [39], that neural stem cells divided in a limited time 
for six days and 10-12 cycles only. The highest good clinical of the 
rats were received in the combination group even though do not 
significant when measured by chi-square test. Maybe this result 
because of some controls could recover spontaneously, and also 
needed larger samples of rats for comparing the clinical outcomes.  
CONCLUSION  
Treatment of SICH with celecoxib or SDF-1 increased the 
quantity of neural stem cells in the lesion zone, but when treated 
with a combination of them did not increase more than a single 
treatment, due to limited of neural stem cells in the nice. The 
clinical outcomes of SICH were not significantly different 
between rats, even though most of the combination treated rats 
were almost normally. Interestingly, grading of proliferation was 
highest in the treatment of SDF-1 compared to another 
treatment, celecoxib or combination. 
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